145 related articles for article (PubMed ID: 30871330)
21. Hypolipemic agents for stroke prevention.
Leys D; Deplanque D; Lucas C; Bordet R
Clin Exp Hypertens; 2002; 24(7-8):573-94. PubMed ID: 12450233
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis for coronary heart disease in heterozygote familial hypercholesterolemia patients.
Sánchez Muñoz-Torrero JF; Rivas MD; Zamorano J; Joya-Vázquez PP; de Isla LP; Padro T; Mata P; The Safeheart Investigators
Per Med; 2018 Mar; 15(2):87-92. PubMed ID: 29714125
[TBL] [Abstract][Full Text] [Related]
23. [Heterozygous familial hypercholesterolemia: the first challenge for anti-PCSK9 monoclonal antibodies].
Zambon A
G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):22S-30. PubMed ID: 27312020
[TBL] [Abstract][Full Text] [Related]
24. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
25. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
[TBL] [Abstract][Full Text] [Related]
26. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
[TBL] [Abstract][Full Text] [Related]
27. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.
Béliard S; Millier A; Carreau V; Carrié A; Moulin P; Fredenrich A; Farnier M; Luc G; Rosenbaum D; Toumi M; Bruckert E;
J Clin Lipidol; 2016; 10(5):1129-1136.e3. PubMed ID: 27678429
[TBL] [Abstract][Full Text] [Related]
28. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
Wadström BN; Wulff AB; Pedersen KM; Jensen GB; Nordestgaard BG
Eur Heart J; 2022 Sep; 43(34):3258-3269. PubMed ID: 34661640
[TBL] [Abstract][Full Text] [Related]
29. A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia.
Langslet G; Breazna A; Drogari E
J Clin Lipidol; 2016; 10(5):1153-1162.e3. PubMed ID: 27678432
[TBL] [Abstract][Full Text] [Related]
30. Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study.
Brunham LR; Cermakova L; Lee T; Priecelova I; Alloul K; de Chantal M; Francis GA; Frohlich J
Can J Cardiol; 2017 Mar; 33(3):385-392. PubMed ID: 27931859
[TBL] [Abstract][Full Text] [Related]
31. Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
Al Kindi M; Bélanger AM; Sayegh K; Senouci S; Aljenedil S; Sivakumaran L; Ruel I; Al Rasadi K; Al Waili K; Awan Z; Valenti D; Genest J
Can J Cardiol; 2017 May; 33(5):658-665. PubMed ID: 28449836
[TBL] [Abstract][Full Text] [Related]
32. Statins and peripheral arterial disease.
Markel A
Int Angiol; 2015 Oct; 34(5):416-27. PubMed ID: 25410295
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.
Ginsberg HN; Rader DJ; Raal FJ; Guyton JR; Baccara-Dinet MT; Lorenzato C; Pordy R; Stroes E
Cardiovasc Drugs Ther; 2016 Oct; 30(5):473-483. PubMed ID: 27618825
[TBL] [Abstract][Full Text] [Related]
34. Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report.
Zenti MG; Stefanutti C; Sanga V; Altomari A; Fabris A; Dauriz M; Bonora E
J Clin Apher; 2018 Aug; 33(4):546-550. PubMed ID: 29638018
[TBL] [Abstract][Full Text] [Related]
35. Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy.
Marco-Benedí V; Laclaustra M; Casado-Dominguez JM; Villa-Pobo R; Mateo-Gallego R; Sánchez-Hernández RM; Blanco Nuez M; Ortega-Martínez de Victoria E; Sitges M; Pedro-Botet J; Puzo J; Villarroel T; Civeira F
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31847331
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes.
Climent E; Pérez-Calahorra S; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Sánchez-Hernández RM; Valdivielso P; Ascaso JF; Pedro-Botet J
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):718-724. PubMed ID: 31672559
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress-responsive apoptosis-inducing protein in patients with heterozygous familial hypercholesterolemia.
Sato K; Yao T; Fujimura T; Murayama K; Okumura K; Hagiwara N; Seko Y
Heart Vessels; 2021 Dec; 36(12):1923-1932. PubMed ID: 34308503
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: a meta-analysis.
Li W; Xu J; Wang X; Chen J; Zhang C; Sun K; Hui R
Atherosclerosis; 2009 Dec; 207(2):492-5. PubMed ID: 19631939
[TBL] [Abstract][Full Text] [Related]
39. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
Foody JM; Vishwanath R
J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia.
Kastelein JJ; Hovingh GK; Langslet G; Baccara-Dinet MT; Gipe DA; Chaudhari U; Zhao J; Minini P; Farnier M
J Clin Lipidol; 2017; 11(1):195-203.e4. PubMed ID: 28391886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
